bpc 157 dosage oral dose BPC-157 Dosing (Common Protocols), πΉ / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or What is the oral dose
Description
Importantly, there were no cardiovascular adverse events, no clinically significant changes in blood pressure or heart rate, no alterations in thyroid function, no immunogenicity with no anti-AOD-9604 antibodies detected, and no signs of tolerance or receptor desensitization
Improved cognitive function
On whether it is better to take BPC-157 orally, the animal gut research is actually encouraging
Vitamin D Injections: Support bone health and immune function
